CALUTADAX-50 – Bicalutamide Tablets IP 50 mg

CALUTADAX-50 – Bicalutamide Tablets IP 50 mg is a prescription oncology medicine used for treating advanced and metastatic prostate cancer.

Bicalutamide works as a non-steroidal anti-androgen, blocking the effects of male hormones (androgens) that stimulate the growth of prostate cancer cells.
It is commonly prescribed along with LHRH agonists (hormone therapy) to improve treatment outcomes.

Effective for:

• Metastatic prostate cancer

• Advanced prostate cancer

• Hormone-sensitive prostate tumors

The medicine is well known for its strong therapeutic efficacy and good tolerability in long-term treatment.

 Key Benefits

• Helps slow or stop the growth of prostate cancer

• Blocks androgen activity effectively

• Used widely in combination therapy

• Supports long-term cancer management

• Well tolerated in most patients

 Directions for Use

• Take exactly as prescribed by your oncologist

• Typically taken once daily

• Can be taken with or without food

• Swallow whole with water

• Do not discontinue treatment without medical advice

 Safety & Precautions

• May cause fatigue, nausea, or hot flashes

• Regular liver function monitoring is advised

• Avoid alcohol

• Inform doctor about any heart or liver conditions

• Not recommended for women or children

• Use caution while driving if dizziness occurs

 Storage

• Store in a cool, dry place

• Protect from sunlight and moisture

• Keep away from children